158
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML

ORCID Icon, , , , , , , , , ORCID Icon, , , , & show all
Pages 3257-3260 | Received 26 May 2022, Accepted 23 Aug 2022, Published online: 08 Sep 2022
 

Acknowledgements

The authors would like to thank Lois Malehorn for editorial assistance.

Disclosure statement

Annie Im has performed consulting from Abbvie and CTI Biopharma and received research funding from Incyte. Alison Sehgal has received research funding from Kite/Gilead, Juno/BMS and Milltenyiz. Michael Boyiadzis is currently an adjunct professor of Medicine at the University of Pittsburgh and an employee of Genentech.

Additional information

Funding

K.L. is supported by the NIH TL1 TR001858. This work is supported by the National Center for Advancing Translational Sciences. This work utilized the Hillman Cancer Center Biostatistics Facility, a shared resource at the University of Pittsburgh supported by the CCSG P30CA047904.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.